Comparing Measures of Adherence and Persistence to P2Y12 Inhibitors in Acute Coronary Syndromes

被引：0
|
作者：
Moon, Jungyeon [1 ]
Ozaki, Aya F. [2 ]
Chong, Alice [3 ]
Sud, Maneesh [4 ]
Fang, Jiming [3 ]
Austin, Peter C. [3 ]
Ko, Dennis T. [3 ,4 ,5 ]
Jackevicius, Cynthia A. [1 ,3 ,4 ,6 ]
机构：
[1] Western Univ Hlth Sci, Coll Pharm, Pomona, CA 91766 USA
[2] Univ Calif Irvine, Sch Pharm & Pharmaceut Sci, Irvine, CA USA
[3] ICES, Toronto, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON, Canada
[6] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2024年 / 226卷
基金：
加拿大健康研究院;
关键词：
clopidogrel; ticagrelor; adherence; persistence; acute coronary syndromes; P2Y12; inhibitors;
D O I：
10.1016/j.amjcard.2024.04.047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：134 / 136
页数：3
相关论文
共 50 条
  • [21] P2Y(12) inhibitors for acute coronary syndromes: current perspectives
    Nawarskas, James J.
    Newsome, Cheyenne
    Anderson, Joe R.
    Ahmed, Bina
    RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2015, 6 : 123 - 143
  • [22] USE OF POTENT P2Y12 INHIBITORS IN AFRICAN-AMERICAN PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES
    Faggioni, Michela
    Baber, Usman
    Chandrasekhar, Jaya
    Vogel, Birgit
    Sartori, Samantha
    Aquino, Melissa
    Kini, Annapoorna
    Weintraub, William
    Kapadia, Samir
    Weiss, Sandra
    Strauss, Craig
    Snyder, Clayton
    Toma, Catalin
    Muhlestein, J.
    DeFranco, Anthony
    Effron, Mark
    Keller, Stuart
    Baker, Brian
    Pocock, Stuart
    Henry, Timothy
    Rao, Sunil
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1273 - 1273
  • [23] The Role of Direct-Acting P2Y12 Inhibitors in Acute Coronary Syndrome
    Buryakina, T. A.
    Zateyshchikov, D. A.
    KARDIOLOGIYA, 2012, 52 (04) : 74 - 79
  • [24] Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
    Baker, William L.
    White, C. Michael
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2009, 9 (04) : 213 - 229
  • [25] Novel Platelet ADP P2Y12 Inhibitors in the Treatment of Acute Coronary Syndrome
    Tan, Guang-Ming
    Lam, Yat-Yin
    Yan, Bryan P.
    CARDIOVASCULAR THERAPEUTICS, 2012, 30 (04) : e167 - e173
  • [26] P2Y12 Receptor Inhibitors: Integrating Ticagrelor into the Management of Acute Coronary Syndrome
    Crouch, Michael A.
    Colucci, Vince J.
    Howard, Patricia A.
    Spinler, Sarah A.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1151 - 1156
  • [27] Ticagrelor: Oral Reversible P2Y12 Receptor Antagonist for the Management of Acute Coronary Syndromes
    Cheng, Judy W. M.
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1209 - 1220
  • [28] Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes
    William L. Baker
    C. Michael White
    American Journal of Cardiovascular Drugs, 2009, 9 : 213 - 229
  • [29] Impact of Aspirin Dosing on the Effects of P2Y12 Inhibition in Patients with Acute Coronary Syndromes
    Mark R. Thomas
    Robert F. Storey
    Journal of Cardiovascular Translational Research, 2014, 7 : 19 - 28
  • [30] P2Y12 inhibitor intensity de-escalation in patients with acute coronary syndromes
    Ndrepepa, Gjin
    Kastrati, Adnan
    EUROPEAN HEART JOURNAL, 2023, 44 (15) : 1371 - 1373
12345